Pharma Focus Asia

Repligen

LATEST NEWSRead more...

14

Jun 2024

BeiGene and NewBridge Pharmaceuticals Conclude Partnership for BRUKINSA® (Zanubrutinib) in the MENA Region

BeiGene a global leader in oncology has decided to end its partnership with NewBridge Pharmaceuticals This decision aligns with BeiGenes strategy to increase its footprint and directly oversee

13

Jun 2024

Innovent Secures Fast Track Status from the FDA for IBI343, a Monotherapy for Advanced Pancreatic Cancer

Innovent Biologics Inc a global leader in biopharmaceuticals focuses on the development manufacturing and commercialization of highquality medicines for various major diseases including oncology

13

Jun 2024

IQVIA Introduces "One Home" Platform to Simplify Clinical Trials and Reduce Site Burden

IQVIA has introduced One Home for Sites a novel technology platform aimed at simplifying clinical trial management This platform provides a unified signon and dashboard integrating various

13

Jun 2024

NSG BioLabs and Eppendorf Group Form Alliance to Enhance Biotech Support in Singapore

NSG BioLabs Singapores largest provider of biotech coworking laboratory and office space has announced a partnership with Eppendorf a prominent global life science company This partnership

12

Jun 2024

DoH and Penn Medicine to Expand Partnership in Translational Research, Opening Additional Labs in Abu Dhabi

The Department of Health Abu Dhabi the regulatory body for healthcare has entered into a second Memorandum of Understanding with the Perelman School of Medicine at the University of Pennsylvania

Solovpe

press releasesRead more...

14

Jun 2024

Record numbers expected at CPHI & PMEC China 2024 as Asian markets boom

CPHI PMEC China June st returns to the Shanghai New International Expo Center amid soaring demand across the pharmaceutical supply chain in Asia China already the primary source of pharmaceutical ingredients and starting materials globally

14

Jun 2024

Sirnaomics Demonstrates Strong Antitumor Activity of Its Novel Oligonucleotide-ChemoDrug Conjugate in Journal of Oncology Research and Therapy

Sirnaomics Ltd a leading biopharmaceutical company in discovery and development of RNAi therapeutics today announced that the Group

14

Jun 2024

SKAN Research Trust and Quadram Institute Bioscience to Develop Novel Microbial Therapies

SKAN Research Trust promoted by Indian entrepreneur Mr Ashok Soota and UKbased Quadram Institute Bioscience today announced that they will apply the cutting

14

Jun 2024

Ethypharm Expands Its Mesalazine (Etiasa®) Portfolio in China

Ethypharm is pleased to announce the acquisition of a suppository form of Mesalazine by its Chinese affiliate Shanghai Ethypharm Pharmaceuticals Ltd from the Chinese Company Jiangsu Anbison Pharmaceutical Leader in essential medicines for central nervous system

14

Jun 2024

Viz.ai Collaborates with Hypertrophic Cardiomyopathy Association to Improve Care for Hypertrophic Cardiomyopathy Patients

Vizai the leader in AIpowered disease detection and intelligent care coordination today announced a collaboration with the Hypertrophic Cardiomyopathy Association the preeminent organization

13

Jun 2024

Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan

Belite Bio Inc a clinicalstage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs

12 - 14

Jun 2024

18 - 19

Jun 2024

18 - 19

Jun 2024

18 - 20

Jun 2024

5th RNA Editing Summit

Boston, MA, USA

19 - 21

Jun 2024

CPHI & PMEC 2024

Shanghai, China

19 - 20

Jun 2024

LogiPharma Asia 2024

Equarius Hotel, Singapore

20 - 22

Jun 2024
Cytiva - Supor Prime filters
MFA + MMA 2024
CPHI China || PMEC China 2024
Asia Healthcare Week 2024
CPHI Korea 2024
World Orphan Drug Congress Europe 2024

TOP ARTICLES

  • 1

    3-dimensional Bioprinting of Tissue and Organs From bench to bedside

    Ryan Varghese

    Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University

    Sahil Salvi

    Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University

    Dileep Kumar

    Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University; Department of Entomology, University of California; UC Davis Comprehensive Cancer Center, University of California. Electronic address: [email protected]

  • 3

    Futuristic Application of Human-On-A-Chip Technology

    Joseph Xavier

    Pursuing PhD, Division of Toxicology, SCTIMST

    Akhil Venugopal

    Junior Research Fellow, Division of Toxicology, SCTIMST

    Arathi Ashok

    Junior Research Fellow, Division of Toxicology, SCTIMST

    PV. Mohanan

    Scientist-G and Head of Division of Toxicology and Associate Dean, SCTIMST

KNOWLEDGE BANK

  • Interviews

    GE Healthcare

    President & CEO

    Our current business focus and strengths are in the areas of bioprocessing proteins cellular analysis cell handling and tools for cell therapy Our strategic intent is to add adjacent technologies or applications which can add value to the overall customer solutions we provideWe are particularly excited about the sample collection and storage opportunity with the FTA product lineWe have a stron...
  • Research Insights

    Thin Films As An Emerging Platform For Drug Delivery

    AbstractPharmaceutical scientists throughout the world are trying to explore thin films as a novel drug delivery tool Thin films have been identified as an alternative approach to conventional dosage forms The thin films are considered to be convenient to swallow selfadministrable and fast dissolving dosage form all of which makes it as a versatile platform

  • White Papers

    Tablet Coating at Low Bed Temperatures with a Novel Coating Polymer

    Currently when coating tablets with moisture sensitive actives aqueous film coatings based on PEG PVA and HPMC are recommended to be applied at high product temperatures to overcome the APIs sensitivity Unfortunately this approach can lead to heat degradation of the API and other potential physical tablet coating defects

EDITORIAL SECTION